Banque Cantonale Vaudoise’s Adaptive Biotechnologies ADPT Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$1K	–	988
2024 Q1	$1K	Hold	300	–	–	﹤0.01%	974
2023 Q4	$1K	Hold	300	–	–	﹤0.01%	1004
2023 Q3	$2K	Hold	300	–	–	﹤0.01%	1162
2023 Q2	$2K	Hold	300	–	–	﹤0.01%	1159
2023 Q1	$3K	Hold	300	–	–	﹤0.01%	1153
2022 Q4	$2K	Hold	300	–	–	﹤0.01%	1166
2022 Q3	$2K	Sell	300 -700	-70%	-$6.59K	﹤0.01%	1211
2022 Q2	$8K	Hold	1,000	–	–	﹤0.01%	1200
2022 Q1	$14K	Hold	1,000	–	–	﹤0.01%	1184
2021 Q4	$28K	Hold	1,000	–	–	﹤0.01%	1153
2021 Q3	$34K	Hold	1,000	–	–	﹤0.01%	1103
2021 Q2	$41K	Buy	1,000 +300	+43%	+$11.7K	﹤0.01%	1066
2021 Q1	$28K	Buy	+700	New	+$37.9K	﹤0.01%	1050
2020 Q3	–	Sell	-686	Closed	-$33K	–	1051
2020 Q2	$33K	Buy	+686	New	+$25K	﹤0.01%	840

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Banque Cantonale Vaudoise's ADPT Position: Q2 2024 in Review

Banque Cantonale Vaudoise sold out of Adaptive Biotechnologies (ADPT) in Q2 2024, closing a stake of 300 shares — an estimated $1K sold.

Banque Cantonale Vaudoise first reported a position in ADPT in Q2 2020 and held it in 14 quarters. The position peaked at $41K in Q2 2021. 176 funds tracked by Wall St. Rank hold ADPT as of Q2 2024.

Banque Cantonale Vaudoise reported no remaining Adaptive Biotechnologies position as of Q2 2024 after selling out during the quarter.
Banque Cantonale Vaudoise sold 300 Adaptive Biotechnologies shares in Q2 2024, an estimated $1K.
Banque Cantonale Vaudoise first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 14 quarters.
Banque Cantonale Vaudoise's Adaptive Biotechnologies position peaked at $41K in Q2 2021.
176 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2024, filed 31 Jul 2024.